In vivo pharmacology of butylthio[2.2.2] (LY297802 / NNC11-1053), an orally acting antinociceptive muscarinic agonist
- 21 February 1997
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 60 (13-14) , 969-976
- https://doi.org/10.1016/s0024-3205(97)00036-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Immunological localization of m1–m5 muscarinic acetylcholine receptors in peripheral tissues and brainPublished by Elsevier ,2002
- Changes in cholinergic and opioid receptors in the rat spinal cord, dorsal root and sciatic nerve after ventral and dorsal root lesionJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1991
- Muscarinic receptor subtypes: implications for lung disease.Thorax, 1989
- A double‐blind trial of the analgesic properties of physostigmine in postoperative patientsActa Anaesthesiologica Scandinavica, 1986
- Muscarinic M1 and M2 receptors mediate depolarization and presynaptic inhibition in guinea‐pig enteric nervous system.The Journal of Physiology, 1985
- MUSCARINIC RECEPTORS IN RAT SYMPATHETIC GANGLIABritish Journal of Pharmacology, 1980
- A comparison of the antinociceptive actions of cholinomimetic and morphine‐like drugsBritish Journal of Pharmacology, 1970
- Studies on the central antinociceptive action of cholinomimetic agentsInternational Journal of Neuropharmacology, 1969
- Treatment of Intractable Pain with Morphine and TetrahydroaminacrineBMJ, 1961
- The Analgetic Action of Morphine, Eserine and Prostigmine Studied by a Modified Hardy‐Wolff‐Goodell Method.Acta Physiologica Scandinavica, 1945